67
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Reston Ebolavirus Antibodies in Bats, the Philippines

      letter

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To the Editor: Filoviruses cause highly lethal hemorrhagic fever in humans and nonhuman primates, except for Reston Ebolavirus (REBOV), which causes severe hemorrhagic fever in macaques ( 1 , 2 ). REBOV epizootics among cynomolgus macaques occurred in 1989, 1990, 1992, and 1996 ( 2 ) and among swine in 2008 ( 3 ). African fruit bats have been suggested to be natural reservoirs for Zaire Ebolavirus and Marburg virus ( 4 – 6 ). However, the natural reservoir of REBOV in the Philippines is unknown. Thus, we determined the prevalence of REBOV antibody–positive bats in the Philippines. Permission for this study was obtained from the Department of Environment and Natural Resources, the Philippines, before collecting bat specimens. Serum specimens from 141 wild-caught bats were collected at several locations during 2008–2009. The bat species tested are summarized in the Table. Captured bats were humanely killed and various tissues were obtained. Carcasses were then provided to the Department of Environment and Natural Resources for issuance of a transport permit. Table REBOV-specific IgG in Rousettus amplexicaudatus bats and other bats, the Philippines* Bat ID Collection site ELISA optical density IFA titer REBOV NP REBOV GP REBOV NP REBOV GP 1539 FD 2.13 –0.21 1,280 <20 1632 FQ1 0.88 0.2 <20 <20 1642 FQ1 0.36 5.22 <20 20 1643 FQ1 1.26 0.92 <20 <20 1651 FQ1 1.61 1.02 <20 <20 1657 FQ1 –0.45 1.69 <20 <20 1660 FQ1 3.8 2.51 640 <20 *Cutoff optical density of ELISA was 0.82 (sum of optical densities at serum dilutions of 1:100, 1:400, 1:1,600, and 1:6,400). Values in boldface are positive results. REBOV, Reston Ebolavirus; Ig, immunoglobulin; IFA, indirect immunofluorescence assay; ID, identification; NP, nucleoprotein; GP, glycoprotein; FD, forest of Diliman at the University of the Philippines Diliman campus; FQ1, forest at the Agricultural College in Province of Quezon, the Philippines. The other 9 R. amplexicaudatus bats collected at FQ1 had negative results for all assays. The following bat species also had negative results: 5 Eonycteris spelaea, 35 Cynopterus brachyotis, 38 Ptenochirus jagoli, 6 Haplonycteris fischeri, 2 Macroglossus minimus, 2 Rhinolophus rufus, 1 Rhinolophus arcuatus, 9 Emballonura alecto, 2 Pipistrellus javanicus, 5 Scotophilus kuhlii, 8 Miniopterus australis, 8 M. schreibersi, 1 M. tristis tritis, 1 Hipposideros diadema, 1 Myotis macrotarsus, and 1 bat of unknown species. We used immunoglobulin (Ig) G ELISAs with recombinant nucleoprotein (NP) and glycoprotein (GP) of REBOV ( 7 ) to determine REBOV antibody prevalence. REBOV NP and GP were expressed and purified from Tn5 cells infected with recombinant baculoviruses AcResNP and AcResGPDTM, which express NP and the ectodomain of GP with the histidine tag at its C-terminus. We also used histidine-tagged recombinant Crimean-Congo hemorrhagic fever virus NP as a negative control antigen in the IgG ELISA to confirm specificity of reactivity. In IgG ELISAs for bat specimens, positive results were detected by using rabbit anti-bat IgG and horseradish peroxidase–conjugated anti-rabbit IgG. Anti-bat (Rousettus aegyptiacus) rabbit IgG strongly cross-reacts with IgGs of other bat species, including insectivorous bats ( 8 ). Bat serum samples were 4-fold serially diluted (1:100–1:6,400) and tested by using IgG ELISAs. Results of IgG ELISAs were the sum of optical densities at serum dilutions of 1:100, 1:400, 1:1,600, and 1:6,400. Cutoff values (0.82 for both IgG ELISAs) were determined by using serum specimens from REBOV antibody–negative bats. Among 16 serum samples from R. amplexicaudatus bats, 5 (31%) captured at either the forest of Diliman (14°38′N, 121°2′E) or the forest of Quezon (14°10′N, 121°50′E) had positive results in the IgG ELISA for REBOV NP, and 5 (31%) captured at the forest of Quezon had positive results in the IgG ELISA for REBOV GP. The REBOV NP antibody–positive bats serum samples were confirmed to be NP antibody positive in the IgG ELISA by using glutathione-S-transferase–tagged partial REBOV NP antigen ( 9 ). Three samples had positive results in both IgG ELISAs (Table). Serum samples from other bat species had negative results in IgG ELISAs. All bat serum samples were also tested by indirect immunofluorescence assays (IFAs) that used HeLa cells expressing NP and GP ( 10 ). In the IFAs, 2 samples from R. amplexicaudatus bats captured at the forest of Diliman and the forest of Quezon had high titers (1,280 and 640, respectively) of NP-specific antibodies, and 1 sample from an R. amplexicaudatus bat captured at the forest of Quezon had a positive result in the GP-specific IFA (titer 20). All IFA-positive samples were also positive in the IgG ELISA (Table). The forest of Diliman is ≈30 km from the monkey facility and the Bulacan farm where REBOV infections in monkeys and swine, respectively, were detected. The forest of Quezon is ≈60 km from the monkey facility. Samples from other bat species had negative results in IFAs. We also performed heminested reverse transcription PCR specific for the REBOV NP gene with spleen specimens from all 16 R. amplexicaudatus bats but failed to detect any REBOV-specific amplicons. REBOV-specific antibodies were detected only in R. amplexicaudatus bats, a common species of fruit bat, in the Philippines. In Africa, R. aegyptiacus bats, which are genetically similar to R. amplexicaudatus bats, have been shown to be naturally infected with Zaire Ebolavirus and Marburg virus. Thus, R. amplexicaudatus bats are a possible natural reservoir of REBOV. However, only 16 specimens of R. amplexicaudatus bats were available in this study, and it will be necessary to investigate more specimens of this species to detect the REBOV genome or antigens to conclude the bat is a natural reservoir for REBOV. We have shown that R. amplexicaudatus bats are putatively infected with REBOV or closely related viruses in the Philippines. Antibody-positive bats were captured at the sites near the study areas, where REBOV infections in cynomolgus monkeys and swine have been identified. Thus, bats are a possible natural reservoir of REBOV. Further analysis to demonstrate the REBOV genome in bats is necessary to conclude that the bat is a reservoir of REBOV.

          Related collections

          Most cited references8

          • Record: found
          • Abstract: found
          • Article: not found

          Discovery of swine as a host for the Reston ebolavirus.

          Since the discovery of the Marburg and Ebola species of filovirus, seemingly random, sporadic fatal outbreaks of disease in humans and nonhuman primates have given impetus to identification of host tropisms and potential reservoirs. Domestic swine in the Philippines, experiencing unusually severe outbreaks of porcine reproductive and respiratory disease syndrome, have now been discovered to host Reston ebolavirus (REBOV). Although REBOV is the only member of Filoviridae that has not been associated with disease in humans, its emergence in the human food chain is of concern. REBOV isolates were found to be more divergent from each other than from the original virus isolated in 1989, indicating polyphyletic origins and that REBOV has been circulating since, and possibly before, the initial discovery of REBOV in monkeys.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Large serological survey showing cocirculation of Ebola and Marburg viruses in Gabonese bat populations, and a high seroprevalence of both viruses in Rousettus aegyptiacus

            Background Ebola and Marburg viruses cause highly lethal hemorrhagic fevers in humans. Recently, bats of multiple species have been identified as possible natural hosts of Zaire ebolavirus (ZEBOV) in Gabon and Republic of Congo, and also of marburgvirus (MARV) in Gabon and Democratic Republic of Congo. Methods We tested 2147 bats belonging to at least nine species sampled between 2003 and 2008 in three regions of Gabon and in the Ebola epidemic region of north Congo for IgG antibodies specific for ZEBOV and MARV. Results Overall, IgG antibodies to ZEBOV and MARV were found in 4% and 1% of bats, respectively. ZEBOV-specific antibodies were found in six bat species (Epomops franqueti, Hypsignathus monstrosus, Myonycteris torquata, Micropteropus pusillus, Mops condylurus and Rousettus aegyptiacus), while MARV-specific antibodies were only found in Rousettus aegyptiacus and Hypsignathus monstrosus. The prevalence of MARV-specific IgG was significantly higher in R. aegyptiacus members captured inside caves than elsewhere. No significant difference in prevalence was found according to age or gender. A higher prevalence of ZEBOV-specific IgG was found in pregnant females than in non pregnant females. Conclusion These findings confirm that ZEBOV and MARV co-circulate in Gabon, the only country where bats infected by each virus have been found. IgG antibodies to both viruses were detected only in Rousettus aegyptiacus, suggesting that this bat species may be involved in the natural cycle of both Marburg and Ebola viruses. The presence of MARV in Gabon indicates a potential risk for a first human outbreak. Disease surveillance should be enhanced in areas near caves.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Epidemiology of Ebola (subtype Reston) virus in the Philippines, 1996.

              Ebola (subtype Reston [EBO-R]) virus infection was detected in macaques imported into the United States from the Philippines in March 1996. Studies were initiated in the Philippines to identify the source of the virus among monkey-breeding and export facilities, to establish surveillance and testing, and to assess the risk and significance of EBO-R infections in humans who work in these facilities. Over a 5-month period, acutely infected animals were found at only one facility, as determined using Ebola antigen detection. Three of 1732 monkeys and 1 of 246 animal handlers tested had detectable antibodies; all were from the same facility, which was the source of infected monkeys imported to the United States. Virus transmission, which was facilitated by poor infection-control practices, continued for several months in one facility and was stopped only when the facility was depopulated. None of the 246 employees of the facilities or 4 contacts of previously antibody-positive individuals reported an Ebola-like illness. This investigation suggests that human EBO-R infection is rare.
                Bookmark

                Author and article information

                Journal
                Emerg Infect Dis
                Emerging Infect. Dis
                EID
                Emerging Infectious Diseases
                Centers for Disease Control and Prevention
                1080-6040
                1080-6059
                August 2011
                : 17
                : 8
                : 1559-1560
                Affiliations
                [1]Author affiliations: University of Tokyo, Tokyo, Japan (S. Taniguchi, S. Watanabe, N. Ueda, K. Iha, H. Fujii, Y. Ishii, S. Kyuwa, H. Akashi, Y. Yoshikawa);
                [2]National Institute of Infectious Diseases, Tokyo (S. Taniguchi, S. Watanabe, T. Omatsu, K. Iha, T. Mizutani, S. Fukushi, M. Saijo, I. Kurane, S. Morikawa);
                [3]University of the Philippines, Laguna, the Philippines (J.S. Masangkay, P. Alviola);
                [4]University of Texas of Medical Branch, Galveston, Texas, USA (T. Ikegami)
                Author notes
                Address for correspondence: Shigeru Morikawa, Special Pathogens Laboratory, Department of Virology 1, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashimurayama, Tokyo 208-0011, Japan; email: morikawa@ 123456nih.go.jp
                Article
                10-1693
                10.3201/eid1708.101693
                3381561
                21801651
                ebbdfe3b-fba2-4d39-bd1b-7b035090ec11
                History
                Categories
                Letters to the Editor

                Infectious disease & Microbiology
                letter,antibodies,reston ebolavirus,ebola,viruses,ebolavirus,bats,the philippines,filoviruses

                Comments

                Comment on this article